Number of the records: 1
Polymer-ritonavir derivate nanomedicine with pH-sensitive activation possesses potent anti-tumor activity in vivo via inhibition of proteasome and STAT3 signaling
- 1.SIVÁK, Ladislav, ŠUBR, Vladimír, KOVÁŘOVÁ, Jiřina, DVOŘÁKOVÁ, Barbora, ŠÍROVÁ, Milada, ŘÍHOVÁ, Blanka, RANDÁROVÁ, Eva, KRAUS, Michal, TOMALA, Jakub, STUDENOVSKÝ, Martin, VONDRÁČKOVÁ, Michaela, SEDLÁČEK, Radislav, MAKOVICKÝ, Peter, FUČÍKOVÁ, J., VOŠAHLÍKOVÁ, Š., SPÍŠEK, R., KOSTKA, Libor, ETRYCH, Tomáš, KOVÁŘ, Marek. Polymer-ritonavir derivate nanomedicine with pH-sensitive activation possesses potent anti-tumor activity in vivo via inhibition of proteasome and STAT3 signaling. Journal of Controlled Release. 2021, 332(APR 10 2021), 563-580. ISSN 0168-3659. E-ISSN 1873-4995. Available: https://doi.org/10.1016/j.jconrel.2021.03.015.
Number of the records: 1